Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$825M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$813M |
| 3 |
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
|
+$802M |
| 4 |
iShares MSCI India ETF
INDA
|
+$743M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$704M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.37B |
| 2 |
Microsoft
MSFT
|
+$2.08B |
| 3 |
NVIDIA
NVDA
|
+$1.74B |
| 4 |
Amazon
AMZN
|
+$1.08B |
| 5 |
Netflix
NFLX
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.41% |
| 2 | Consumer Discretionary | 1.14% |
| 3 | Financials | 1.02% |
| 4 | Healthcare | 0.75% |
| 5 | Industrials | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDTX
8676
DELISTED
Cidara Therapeutics
CDTX
| $42.1K | ﹤0.01% |
2,287
+1,599
| +232% | +$23K |
|
8677
CALL
D-Wave Quantum Inc. Common Stock
QBTS
$7.61B
| $42K | ﹤0.01% |
+20,600
| New | +$29K |
|
|
IPHA
8678
Innate Pharma
IPHA
$208M
| $41.9K | ﹤0.01% |
+14,554
| New | +$38.1K |
|
8679
Primech Holdings
PMEC
$16.8M
| $41.8K | ﹤0.01% |
+32,404
| New | +$77.1K |
|
|
MIN
8680
Aberdeen Intermediate Income Fund
MIN
$278M
| $41.6K | ﹤0.01% |
+15,657
| New | +$42.7K |
|
|
DHC
8681
CALL
Diversified Healthcare Trust
DHC
$2.03B
| $41.1K | ﹤0.01% |
16,700
-22,400
| -57% | -$64.2K |
|
8682
Compass Therapeutics
CMPX
$384M
| $40.9K | ﹤0.01% |
20,673
-62,412
| -75% | -$108K |
|
8683
Angi Inc
ANGI
$184M
| $40.4K | ﹤0.01% |
1,542
-9,696
| -86% | -$247K |
|
8684
CALL
Coeur Mining
CDE
$18.4B
| $40.3K | ﹤0.01% |
10,700
-218,300
| -95% | -$629K |
|
|
GRND.WS
8685
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
| $39.8K | ﹤0.01% |
17,232
-32,839
| -66% | -$63.9K |
|
8686
Waldencast PLC Warrant
WALDW
$3.8M
| $39.8K | ﹤0.01% |
+71,066
| New | +$48.6K |
|
|
HITI
8687
High Tide
HITI
$199M
| $39.3K | ﹤0.01% |
+19,700
| New | +$35.3K |
|
8688
Immuneering
IMRX
$296M
| $38.8K | ﹤0.01% |
+13,438
| New | +$75.3K |
|
8689
CALL
Gevo
GEVO
$385M
| $38.7K | ﹤0.01% |
50,400
-2,700
| -5% | -$2.35K |
|
8690
Castor Maritime
CTRM
$20M
| $38.6K | ﹤0.01% |
11,230
+2,930
| +35% | +$13.4K |
|
8691
Volato Group
SOAR
$8.88M
| $38.2K | ﹤0.01% |
+431
| New | +$36.1K |
|
8692
Vuzix
VUZI
$225M
| $38.1K | ﹤0.01% |
31,508
-27,159
| -46% | -$44.3K |
|
8693
Aterian
ATER
$5.24M
| $37.9K | ﹤0.01% |
13,717
+10,667
| +350% | +$45.4K |
|
8694
Ondas Inc
ONDS
$5.23B
| $37.9K | ﹤0.01% |
39,020
-37,808
| -49% | -$49.7K |
|
8695
Spectral AI
MDAI
$55.1M
| $37.4K | ﹤0.01% |
+17,549
| New | +$39.7K |
|
8696
Nektar Therapeutics
NKTR
$2.54B
| $37K | ﹤0.01% |
2,644
-6,566
| -71% | -$68.7K |
|
|
EXK
8697
CALL
Endeavour Silver
EXK
$2.99B
| $36.9K | ﹤0.01% |
15,300
-4,600
| -23% | -$8.19K |
|
8698
CALL
Sabre
SABR
$823M
| $36.8K | ﹤0.01% |
15,200
-25,900
| -63% | -$86.9K |
|
8699
Protalix BioTherapeutics
PLX
$195M
| $36.4K | ﹤0.01% |
28,921
+96
| +0.3% | +$143 |
|
8700
Franklin Wireless
FKWL
$28M
| $36.3K | ﹤0.01% |
12,136
-4,664
| -28% | -$13.9K |
|
Similar funds
Jane Street's Q1 2024 Portfolio in Review
As of Q1 2024, Jane Street held 10,498 positions worth $478B, up 25% from $384B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Jane Street deployed $55.3B of net new capital in Q1 2024, opening 1,391 new positions and adding to 3,225 existing holdings. Its largest new stake was iShares MSCI EAFE Value ETF: 9,907,136 shares worth $539M.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 4.4% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.37B trimmed.
- Jane Street's largest Q1 2024 buy was iShares MSCI EAFE Value ETF: 9,907,136 shares worth $539M.
- Jane Street added most to iShares MSCI ACWI ETF in Q1 2024, an estimated $825M increase.
- Jane Street's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.37B.
- Jane Street fully exited JPMorgan Ultra-Short Income ETF in Q1 2024, selling an estimated $302M.
- Jane Street's ten largest holdings make up 51% of its $478B portfolio in Q1 2024.
- Jane Street opened 1,391 new positions and closed 1,402 in Q1 2024.
- Jane Street's portfolio value rose 25% quarter-over-quarter to $478B.
Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.